SBIR/STTR Research Award

Balloon Angioplasty Inflation Device

Award identifier f617c48743ca028a382beab8f0b976b8116cd71b842ff695308a3f94b70be5deAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$224,952

Program and phase

SBIR · Phase I

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Minnesota HealthSolutions Corporation
Proposal award date
2017-09-15
Contract end date
2018-08-31
UEI
G34WKGPA1M73
Solicitation number
PA16-302
Topic code
N

Research abstract

Project Summary Abstract We propose the development of a novel balloon angioplasty inflation device for improving the safety and efficacy of balloon angioplasty Atherosclerosis is associated with coronary artery disease ischemic stroke and peripheral arterial disease Percutaneous balloon angioplasty often in conjunction with stent device deployment has been associated with prolonged survival increased quality of life and extended delay of restenosis There exists great enthusiasm for percutaneous interventions to resolve atherosclerotic symptoms Balloon inflation devices on the market do not adequately consider the molecular composition of the artery nor do they consider elasticity differences between arterial beds The proposed project explores a novel technique to promote improved inflation performance during balloon angioplasty resulting in less stress on the artery wall to achieve resultant luminal area A prototype device will be developed and evaluated Project Narrative Atherosclerosis is the leading cause of vascular disease which accounts for of all deaths in North America Coronary artery disease is the leading cause of death from atherosclerosis with over deaths per year in the US alone Peripheral artery disease affects more than million persons worldwide including at least million persons in the United States and is associated with high rates of cardiovascular events and death as well Percutaneous intervention via balloon angioplasty is a common treatment for atherosclerosis In coronary artery treatments up to of all conventional procedures result in angiographically significant coronary dissection The most significant risk factor for perforation is oversizing the balloon diameter for the artery under treatment We propose to develop a novel device to improve the safety and efficacy of balloon angioplasty

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

66 SBIR/STTR records share this UEI (2007–2025). Reported award amounts total $44,761,119. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Education, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.